A citation-based method for searching scientific literature

Melissa A C Ingram, Harry T Orr, H Brent Clark. Brain Res Bull 2012
Times Cited: 13







List of co-cited articles
123 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type 2.
Jing Liu, Tie-Shan Tang, Huiping Tu, Omar Nelson, Emily Herndon, Duong P Huynh, Stefan M Pulst, Ilya Bezprozvanny. J Neurosci 2009
192
30

Changes in Purkinje cell firing and gene expression precede behavioral pathology in a mouse model of SCA2.
Stephen T Hansen, Pratap Meera, Thomas S Otis, Stefan M Pulst. Hum Mol Genet 2013
111
30


Trinucleotide repeat disorders.
Harry T Orr, Huda Y Zoghbi. Annu Rev Neurosci 2007
992
23

Abnormalities in the climbing fiber-Purkinje cell circuitry contribute to neuronal dysfunction in ATXN1[82Q] mice.
Justin A Barnes, Blake A Ebner, Lisa A Duvick, Wangcai Gao, Gang Chen, Harry T Orr, Timothy J Ebner. J Neurosci 2011
54
23

Recovery from polyglutamine-induced neurodegeneration in conditional SCA1 transgenic mice.
Tao Zu, Lisa A Duvick, Michael D Kaytor, Michael S Berlinger, Huda Y Zoghbi, H Brent Clark, Harry T Orr. J Neurosci 2004
195
23


RNA therapy for polyglutamine neurodegenerative diseases.
Lauren M Watson, Matthew J A Wood. Expert Rev Mol Med 2012
10
30

SCA1 transgenic mice: a model for neurodegeneration caused by an expanded CAG trinucleotide repeat.
E N Burright, H B Clark, A Servadio, T Matilla, R M Feddersen, W S Yunis, L A Duvick, H Y Zoghbi, H T Orr. Cell 1995
467
23

Consensus paper: pathological mechanisms underlying neurodegeneration in spinocerebellar ataxias.
A Matilla-Dueñas, T Ashizawa, A Brice, S Magri, K N McFarland, M Pandolfo, S M Pulst, O Riess, D C Rubinsztein, J Schmidt,[...]. Cerebellum 2014
84
23


Ataxia and epileptic seizures in mice lacking type 1 inositol 1,4,5-trisphosphate receptor.
M Matsumoto, T Nakagawa, T Inoue, E Nagata, K Tanaka, H Takano, O Minowa, J Kuno, S Sakakibara, M Yamada,[...]. Nature 1996
349
23

Mutant ataxin-3 with an abnormally expanded polyglutamine chain disrupts dendritic development and metabotropic glutamate receptor signaling in mouse cerebellar Purkinje cells.
Ayumu Konno, Anton N Shuvaev, Noriko Miyake, Koichi Miyake, Akira Iizuka, Serina Matsuura, Fathul Huda, Kazuhiro Nakamura, Shigeru Yanagi, Takashi Shimada,[...]. Cerebellum 2014
52
23

Cellular and molecular pathways triggering neurodegeneration in the spinocerebellar ataxias.
Antoni Matilla-Dueñas, Ivelisse Sánchez, Marc Corral-Juan, Antoni Dávalos, Ramiro Alvarez, Pilar Latorre. Cerebellum 2010
65
23



Spinocerebellar ataxia type 2: polyQ repeat variation in the CACNA1A calcium channel modifies age of onset.
Stefan-M Pulst, Nieves Santos, Dai Wang, Huiying Yang, Duong Huynh, Luis Velazquez, K Pattie Figueroa. Brain 2005
95
23

The wide spectrum of spinocerebellar ataxias (SCAs).
Mario-Ubaldo Manto. Cerebellum 2005
192
23

RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia.
Haibin Xia, Qinwen Mao, Steven L Eliason, Scott Q Harper, Inês H Martins, Harry T Orr, Henry L Paulson, Linda Yang, Robert M Kotin, Beverly L Davidson. Nat Med 2004
493
23

Bergmann glia expression of polyglutamine-expanded ataxin-7 produces neurodegeneration by impairing glutamate transport.
Sara K Custer, Gwenn A Garden, Nishi Gill, Udo Rueb, Randell T Libby, Christian Schultz, Stephan J Guyenet, Thomas Deller, Lesnick E Westrum, Bryce L Sopher,[...]. Nat Neurosci 2006
175
15


Polyglutamine-expanded ataxin-7 causes cerebellar dysfunction by inducing transcriptional dysregulation.
An-Hsun Chou, Chia-Yang Chen, Si-Ying Chen, Wei-June Chen, Ying-Ling Chen, Yi-Shin Weng, Hung-Li Wang. Neurochem Int 2010
48
15

Huntingtin spheroids and protofibrils as precursors in polyglutamine fibrilization.
Michelle A Poirier, Huilin Li, Jed Macosko, Shuowei Cai, Mario Amzel, Christopher A Ross. J Biol Chem 2002
280
15

SCA1-like disease in mice expressing wild-type ataxin-1 with a serine to aspartic acid replacement at residue 776.
Lisa Duvick, Justin Barnes, Blake Ebner, Smita Agrawal, Michael Andresen, Janghoo Lim, Glenn J Giesler, Huda Y Zoghbi, Harry T Orr. Neuron 2010
108
15

Intravitreal administration of HA-1077, a ROCK inhibitor, improves retinal function in a mouse model of huntington disease.
Mei Li, Douglas Yasumura, Aye Aye K Ma, Michael T Matthes, Haidong Yang, Gregory Nielson, Yong Huang, Francis C Szoka, Matthew M Lavail, Marc I Diamond. PLoS One 2013
37
15

Methylene blue modulates huntingtin aggregation intermediates and is protective in Huntington's disease models.
Emily Mitchell Sontag, Gregor P Lotz, Namita Agrawal, Andrew Tran, Rebecca Aron, Guocheng Yang, Mihaela Necula, Alice Lau, Steven Finkbeiner, Charles Glabe,[...]. J Neurosci 2012
67
15



Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death.
Montserrat Arrasate, Siddhartha Mitra, Erik S Schweitzer, Mark R Segal, Steven Finkbeiner. Nature 2004
15

Identification of potential therapeutic drugs for huntington's disease using Caenorhabditis elegans.
Cindy Voisine, Hemant Varma, Nicola Walker, Emily A Bates, Brent R Stockwell, Anne C Hart. PLoS One 2007
97
15

Cytosolic chaperonin prevents polyglutamine toxicity with altering the aggregation state.
Akira Kitamura, Hiroshi Kubota, Chan-Gi Pack, Gen Matsumoto, Shoshiro Hirayama, Yasuo Takahashi, Hiroshi Kimura, Masataka Kinjo, Richard I Morimoto, Kazuhiro Nagata. Nat Cell Biol 2006
201
15

Modifiers of mutant huntingtin aggregation: functional conservation of C. elegans-modifiers of polyglutamine aggregation.
Eva Teuling, Annika Bourgonje, Sven Veenje, Karen Thijssen, Jelle de Boer, Joeri van der Velde, Morris Swertz, Ellen Nollen. PLoS Curr 2011
13
15

Identification of genes that modify ataxin-1-induced neurodegeneration.
P Fernandez-Funez, M L Nino-Rosales, B de Gouyon, W C She, J M Luchak, P Martinez, E Turiegano, J Benito, M Capovilla, P J Skinner,[...]. Nature 2000
487
15


Green tea (-)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models.
Dagmar E Ehrnhoefer, Martin Duennwald, Phoebe Markovic, Jennifer L Wacker, Sabine Engemann, Margaret Roark, Justin Legleiter, J Lawrence Marsh, Leslie M Thompson, Susan Lindquist,[...]. Hum Mol Genet 2006
270
15

Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons.
J Alex Parker, Margarita Arango, Salima Abderrahmane, Emmanuel Lambert, Cendrine Tourette, Hélène Catoire, Christian Néri. Nat Genet 2005
380
15

Large-scale functional RNAi screen in C. elegans identifies genes that regulate the dysfunction of mutant polyglutamine neurons.
François-Xavier Lejeune, Lilia Mesrob, Frédéric Parmentier, Cedric Bicep, Rafael P Vazquez-Manrique, J Alex Parker, Jean-Philippe Vert, Cendrine Tourette, Christian Neri. BMC Genomics 2012
43
15

Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease.
Brinda Ravikumar, Coralie Vacher, Zdenek Berger, Janet E Davies, Shouqing Luo, Lourdes G Oroz, Francesco Scaravilli, Douglas F Easton, Rainer Duden, Cahir J O'Kane,[...]. Nat Genet 2004
15

Genome-wide RNA interference screen identifies previously undescribed regulators of polyglutamine aggregation.
Ellen A A Nollen, Susana M Garcia, Gijs van Haaften, Soojin Kim, Alejandro Chavez, Richard I Morimoto, Ronald H A Plasterk. Proc Natl Acad Sci U S A 2004
284
15

Differential contributions of Caenorhabditis elegans histone deacetylases to huntingtin polyglutamine toxicity.
Emily A Bates, Martin Victor, Adriana K Jones, Yang Shi, Anne C Hart. J Neurosci 2006
116
15

Polyglutamine-mediated dysfunction and apoptotic death of a Caenorhabditis elegans sensory neuron.
P W Faber, J R Alter, M E MacDonald, A C Hart. Proc Natl Acad Sci U S A 1999
218
15

Molecular genetics and biomarkers of polyglutamine diseases.
Masahisa Katsuno, Haruhiko Banno, Keisuke Suzuki, Yu Takeuchi, Motoshi Kawashima, Fumiaki Tanaka, Hiroaki Adachi, Gen Sobue. Curr Mol Med 2008
37
15


Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1.
H T Orr, M Y Chung, S Banfi, T J Kwiatkowski, A Servadio, A L Beaudet, A E McCall, L A Duvick, L P Ranum, H Y Zoghbi. Nat Genet 1993
15

A transgenic mouse model of spinocerebellar ataxia type 3 resembling late disease onset and gender-specific instability of CAG repeats.
Jana Boy, Thorsten Schmidt, Ulrike Schumann, Ute Grasshoff, Samy Unser, Carsten Holzmann, Ina Schmitt, Tim Karl, Franco Laccone, Hartwig Wolburg,[...]. Neurobiol Dis 2010
41
15

Brain pathology of spinocerebellar ataxias.
Kay Seidel, Sonny Siswanto, Ewout R P Brunt, Wilfred den Dunnen, Horst-Werner Korf, Udo Rüb. Acta Neuropathol 2012
228
15

TRPC channels: integrators of multiple cellular signals.
J Soboloff, M Spassova, T Hewavitharana, L P He, P Luncsford, W Xu, K Venkatachalam, D van Rossum, R L Patterson, D L Gill. Handb Exp Pharmacol 2007
33
15

Impaired motor coordination correlates with persistent multiple climbing fiber innervation in PKC gamma mutant mice.
C Chen, M Kano, A Abeliovich, L Chen, S Bao, J J Kim, K Hashimoto, R F Thompson, S Tonegawa. Cell 1995
267
15

Emerging pathogenic pathways in the spinocerebellar ataxias.
Kerri M Carlson, J Michael Andresen, Harry T Orr. Curr Opin Genet Dev 2009
57
15



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.